Cashu
HeartBeam Innovates Cardiac Care with New Funding and Cable-Free ECG Technology
about 1 year ago
Stocks
Health Care
beat
HeartBeam
NASDAQ: BEAT
0.00 (+0.37%)
1.355
USD
At close at Mar 11, 20:45 UTC
Overview
Loading chart...
Key Stats
Market Cap
46.66M
Dividend Yield
0.00%
P/E Ratio
-2.26
EPS
-0.74
Revenue
-
Avg. Volume
7.37M
About
What does BEAT do?
HeartBeam, a development stage company based in Santa Clara, California, focuses on advanced cardiovascular diagnostic technology and went public on October 14, 2021. They are developing proprietary VECG technology and two patented products, HeartBeam AIMI and HeartBeam AIMIGo, for cardiac disease detection and monitoring.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.